22 August 2025 marked a milestone moment for the medical device industry in Southeast Asia, as the Medical Device Authority (MDA) and the...

As part of its ongoing efforts to streamline regulatory processes and ensure better clarity for applicants, the Health Sciences Authority...

On 28 July 2025, the National Medical Products Administration (NMPA) officially issued two new information standards that will come into...

Since 1 November 2023, Hong Kong has embraced the “1+ mechanism” , a progressive pathway for registering new drugs. Under this system,...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has been officially designated as a WHO-Listed Authority (WLA)  by...

In a landmark move for international medical device regulation, the Medical Device Authority (MDA) and National Medical Products...

In a continued effort to strengthen the quality and efficiency of regulatory assessments, the National Pharmaceutical Regulatory Agency...

In its ongoing efforts to streamline pharmaceutical regulatory procedures and embrace digital transformation, the Central Drugs Standard...

In a world where healthcare innovation often outpaces regulations, one country is stepping forward to bridge that gap with confidence,...

As the digital health landscape continues to evolve rapidly, the Health Sciences Authority (HSA) released the Revision 2 (R2)  of its...

In a strategic move to become a global hub for healthcare innovation, the Department of Health (DH) has announced a detailed timetable...

The Health Sciences Authority (HSA) has announced the implementation of revised GN-21, which is set to take effect on 14 July 2025 . This...